Study Finds Targeted Cancer Drugs May Work In Range Of Tumor Types (ASCO)
The researchers said the trial will expand those groups of patients, as well as a separate group with BRAF mutations in lung cancer who were treated with Zelboraf, which is approved for melanoma.
The researchers said the trial will expand those groups of patients, as well as a separate group with BRAF mutations in lung cancer who were treated with Zelboraf, which is approved for melanoma.